Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-05 4:00 pm Purchase | 2025-08-31 | 13G | KATAPULT HLDGS INC KPLT | Blue Owl Capital Holdings LP | 667,685 12.760% | 667,685 (New Position) | Filing History |
| 2025-08-11 5:57 pm Purchase | 2025-06-30 | 13G | BIOMEA FUSION INC BMEA | Blue Owl Capital Holdings LP | 3,800,000 6.130% | 3,800,000 (New Position) | Filing History |
| 2025-05-15 4:13 pm Purchase | 2025-03-31 | 13G | MARKER THERAPEUTICS INC MRKR | Blue Owl Capital Holdings LP | 1,127,052 9.990% | 572,802 (+103.35%) | Filing History |
| 2025-02-14 5:09 pm Sale | 2024-12-31 | 13G | SAGIMET BIOSCIENCES INC SER A SGMT | Blue Owl Capital Holdings LP | 1,323,877 4.320% | -350,000 (-20.91%) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 6,357,928 8.480% | 2,266,810 (+55.41%) | Filing History |
| 2025-02-14 5:09 pm Sale | 2024-12-31 | 13G | AEON BIOPHARMA INC AEON | Blue Owl Capital Holdings LP | 42,352 3.810% | -4,054 (-8.74%) | Filing History |
| 2025-02-14 5:09 pm Sale | 2024-12-31 | 13G | Tourmaline Bio, Inc. TRML | Blue Owl Capital Holdings LP | 1,079,321 4.200% | -451,080 (-29.47%) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | MARKER THERAPEUTICS INC MRKR | Blue Owl Capital Holdings LP | 554,250 5.180% | 554,250 (New Position) | Filing History |
| 2025-02-14 5:09 pm Sale | 2024-12-31 | 13G | GENERATION ASIA I ACQ LTD GAQ | Blue Owl Capital Holdings LP | 0 0.000% | -573,000 (Position Closed) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | FS CR OPPORTUNITIES CORP COM FSCO | Blue Owl Capital Holdings LP | 50,000 16.670% | 50,000 (New Position) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | LUMENT FIN TR INC RED LFTPRA | Blue Owl Capital Holdings LP | 200,000 8.330% | 200,000 (New Position) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | ARBOR RLTY TR INC ABRPRE | Blue Owl Capital Holdings LP | 360,000 6.260% | 360,000 (New Position) | Filing History |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | SYROS PHARMACEUTICALS INC SYRS | Blue Owl Capital Holdings LP | 515,855 1.920% | -977,397 (-65.45%) | Filing History |
| 2024-11-14 5:05 pm Unchanged | 2024-09-30 | 13G | PLIANT THERAPEUTICS INC PLRX | Blue Owl Capital Holdings LP | 3,004,199 4.940% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | CULLINAN THERAPEUTICS INC CGEM | Blue Owl Capital Holdings LP | 2,010,972 3.450% | -1,408,870 (-41.20%) | Filing History |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | Blue Owl Capital Holdings LP | 0 0.000% | -15,596,600 (Position Closed) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | ENGENE HLDGS INC ENGN | Blue Owl Capital Holdings LP | 3,095,069 7.000% | 1,860,309 (+150.66%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | Blue Owl Capital Holdings LP | 1,530,401 6.000% | 198,099 (+14.87%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | LARIMAR THERAPEUTICS INC LRMR | Blue Owl Capital Holdings LP | 4,166,829 6.530% | 752,361 (+22.03%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | REPARE THERAPEUTICS INC RPTX | Blue Owl Capital Holdings LP | 3,372,499 7.930% | 250,000 (+8.01%) | Filing History |